欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/V/0283/001
药品名称Covexin 10
活性成分
    • C. chauvoei whole culture 0.0 [no unit]
    • C. novyi Type B toxcid 0.0 [no unit]
    • C. perfringens Type A Toxcid 0.0 ml
    • C. perfringens Type B & C toxcid 0.0 ml
    • C. perfringens Type D toxcid 0.0 ml
    • C. septicum toxcid 0.0 [no unit]
    • C. sordellii toxcid 0.0 [no unit]
    • C. tetani toxcid 0.0 [no unit]
剂型Suspension for injection
上市许可持有人Zoetis Belgium SA, Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve AL7 1TW
参考成员国 - 产品名称Germany (DE)
Covexin Zehn
互认成员国 - 产品名称
    • Croatia (HR)
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Belgium (BE)
      Covexin 10
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • United Kingdom (Northern Ireland) (XI)
      Covexin 10 Suspension for Injection for Sheep and Cattle
许可日期2008/04/05
最近更新日期2024/07/17
药物ATC编码
    • QI02AB01 clostridium
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase